Solubilization and targeted delivery of drugs with self-assembling amphiphilic polymers
There are provided amphiphilic biodegradable copolymers comprising a hydrophilic backbone with pendant aliphatic groups as the hydrophobic component. The polymers form nanoscale molecular aggregates in aqueous environments, which have hydrophobic interiors that are capable of solubilizing insoluble organic compounds such as drugs, vitamins, dyes, and imaging agents. The polymers optionally feature reactive functional groups that provide attachment points for antibodies, ligands, and other targeting moieties useful for the targeted delivery of drugs and imaging agents.
1. A comb polymer consisting essentially of the following structure:
comprising a backbone formed of alternating branch-point moieties B and hydrophilic, water-soluble polymer blocks A; and having hydrophobic side chains C attached to the branch-point moieties, wherein each side chain C is independently selected from the group consisting of linear hydrocarbons optionally substituted with one or more hydrophilic substituents, polycyclic hydrocarbons optionally substituted with one or more hydrophilic substituents, hydrophobic amino acids, peptides and polymers; wherein n ranges from 3 to about 100; and wherein, on average, 1<p≦4.
2. The polymer of claim 1 , wherein, on average, p ranges from about 2 up to 4.
3. The polymer of claim 1 , wherein, on average, 1.5≦p≦2.
4. A polymer according to claim 1 , further comprising one or more reactive functional groups X attached to each branch-point moiety, and consisting essentially of the following structure:
wherein, on average, r ranges from about 1 to about 4.
5. The polymer of any of claims 1 - 4 , wherein the water-soluble polymer block A is selected from the group consisting of poly(ethylene glycol), poly(propylene glycol), poly(ethylene imine), poly(vinyl alcohol), poly(vinylpyrrolidone), and polysaccharides, and copolymers thereof.
6. The polymer of claim 5 , wherein the polymer block A is selected from the group consisting of poly(ethylene glycol) and poly(propylene glycol), and copolymers thereof.
7. The polymer of claim 6 , wherein the polymer block A is poly(ethylene glycol).
8. The polymer of claim 7 , wherein the polymer block A has an average length of between 4 and 700 monomer units.
9. The polymer of claim 4 , having the structure
wherein m is 4-700, and Y and Y′ are independently selected from the group consisting of R, OR, COOR, SR, NHR, NRR′, ONHR, NHOR, NRNH 2 , NHNHR, NRNHR′, and NHNRR′, wherein R and R′ are independently selected from the group consisting of linear hydrocarbons optionally substituted with one or more hydrophilic substituents, polycyclic hydrocarbons optionally substituted with one or more hydrophilic substituents, hydrophobic amino acids, peptides and polymers.
10. The polymer of claim 4 , having the structure
wherein m is 4-700, and Y and Y′ are independently selected from the group consisting of R, COR, COOR, CONHR, CONRR′, CONHOR, CONRNH 2 , CONHNHR, CONRNHR′, and CONHNRR′, wherein R and R′ are independently selected from the group consisting of linear hydrocarbons optionally substituted with one or more hydrophilic substituents, polycyclic hydrocarbons optionally substituted with one or more hydrophilic substituents, hydrophobic amino acids, peptides and polymers.
11. The polymer of claim 4 , having the structure
wherein m is 4-700, and Y and Y′ are independently selected from the group consisting of R, OR, COOR, SR, NHR, NRR′, ONHR, NHOR, NRNH 2 , NHNHR, NRNHR′, and NHNRR′, wherein R and R′ are independently selected from the group consisting of linear hydrocarbons optionally substituted with one or more hydrophilic substituents, polycyclic hydrocarbons optionally substituted with one or more hydrophilic substituents, hydrophobic amino acids, peptides and polymers.
12. The polymer of claim 3 , having the structure
wherein m is 4-700, and Y and Y′ are independently selected from the group consisting of R, OR, COOR, SR, NHR, NRR′, ONHR, NHOR, NRNH 2 , NHNHR, NRNHR′, and NHNRR′, wherein R and R′ are independently selected from the group consisting of linear hydrocarbons optionally substituted with one or more hydrophilic substituents, polycyclic hydrocarbons optionally substituted with one or more hydrophilic substituents, hydrophobic amino acids, peptides and polymers.
13. The polymer of claim 3 , having the structure
wherein m is 4-700, and Y and Y′ are independently selected from the group consisting of R, OR, COOR, SR, NHR, NRR′, ONHR, NHOR, NRNH 2 , NHNHR, NRNHR′, and NHNRR′, wherein R and R′ are independently selected from the group consisting of linear hydrocarbons optionally substituted with one or more hydrophilic substituents, polycyclic hydrocarbons optionally substituted with one or more hydrophilic substituents, hydrophobic amino acids, peptides and polymers.
14. The polymer of claim 3 , having the structure
wherein the moiety D is derived from a diamine having the general structure
each X is independently a reactive functional group, p is 0-4, and m is 4-700; and wherein R and R′ are independently selected from the group consisting of linear hydrocarbons optionally substituted with one or more hydrophilic substituents, polycyclic hydrocarbons optionally substituted with one or more hydrophilic substituents, hydrophobic amino acids, peptides and polymers.
15. The polymer of claim 4 , having the structure
wherein m is 4-700, and R and R′ are independently selected from the group consisting of linear hydrocarbons optionally substituted with one or more hydrophilic substituents, polycyclic hydrocarbons optionally substituted with one or more hydrophilic substituents, hydrophobic amino acids, peptides and polymers.
16. The polymer of claim 4 , having the structure
wherein m is 4-700, L is phenylene, C 2 -C 6 alkylene, or benzenedimethylene, and R and R′ are independently selected from the group consisting of linear hydrocarbons optionally substituted with one or more hydrophilic substituents, polycyclic hydrocarbons optionally substituted with one or more hydrophilic substituents, hydrophobic amino acids, peptides and polymers.
17. The composition resulting from the chemical reaction of polyethylene glycol and maleic anhydride, resulting in the substantially complete esterification of the terminal hydroxyl groups of the polyethylene glycol by the maleic anhydride, and chemical reaction of the resulting material with dithiothreitol.
18. The composition resulting from the chemical reaction of polypropylene glycol and maleic anhydride, resulting in the substantially complete esterification of the terminal hydroxyl groups of the polypropylene glycol by the maleic anhydride, and chemical reaction of the resulting material with dithiothreitol.
19. A polymer having the structure
wherein m is 4 to about 700 and n is 3 to about 100, and wherein, in each occurrence of the monomer unit having the structure shown, Y and Y′ are independently selected from the group consisting of OH, COOH, SH, NH 2 , NHR, ONH 2 , NHOH, NHNH 2 , and NRNH 2 , wherein R is selected from the group consisting of C 1 to C 5 alkyl and (CH 2 ) k OH, (CH 2 ) k COOH, (CH 2 ) k SH, (CH 2 ) k NH 2 , (CH 2 ) k ONH 2 , (CH 2 ) k NHOH, and (CH 2 ) k NHNH 2 , where k is from 2 to 5.
20. A polymer having the structure
wherein m is 4 to about 700 and n is 3 to about 100, and wherein, in each occurrence of the monomer unit having the structure shown, Y and Y′ are independently selected from the group consisting of OH, COOH, SH, NH 2 , NHR, ONH 2 , NHOH, NRNH 2 , and NRNH 2 , wherein R is selected from the group consisting of C 1 to C 5 alkyl and (CH 2 ) k OH, (CH 2 ) k COOH, (CH 2 ) k SH, (CH 2 ) k NH 2 , (CH 2 ) k ONH 2 , (CH 2 ) k NHOH, and (CH 2 ) k NHNH 2 , where k is from 2 to 5; W and W′ are independently O or H 2 , and wherein, in each occurrence of the monomer unit, Z and Z′ are independently selected from the group consisting of linear hydrocarbons optionally substituted with one or more hydrophilic substituents, polycyclic hydrocarbons optionally substituted with one or more hydrophilic substituents, hydrophobic amino acids, peptides and polymers.
21. A polymer having the structure
wherein m is 4-700, and Y and Y′ are independently selected from the group consisting of R, OR, COOR, SR, NHR, NRR′, ONHR, NHOR, NRNH 2 , NHNHR, NRNHR′, and NHNRR′, wherein R and R′ are independently selected from the group consisting of linear hydrocarbons optionally substituted with one or more hydrophilic substituents, polycyclic hydrocarbons optionally substituted with one or more hydrophilic substituents, hydrophobic amino acids, peptides and polymers; and wherein, in each occurrence of the monomer unit, W and W′ are independently selected from the group consisting of H, —COCH═CH 2 , —COC(CH 3 )═CH 2 , COCH═CHCO 2 H, and —COC(CH 3 )═CHCO 2 H.
22. A pharmaceutical composition comprising a polymer according to any of claims 1 - 9 , and further comprising an effective amount of a pharmacologically active agent.
23. A method of increasing the solubility of a substance in an aqueous solvent, which comprises contacting the substance with a polymer according to claim 1 or claim 2 so as to form a water-soluble complex of the substance and the polymer.
24. A method of increasing the solubility of a substance in a non-aqueous solvent, which comprises contacting the substance with a polymer according to claim 1 or claim 2 so as to form a complex of the substance and the polymer that is soluble in the non-aqueous solvent.
25. The method of claim 23 , wherein the substance is selected from the group consisting of vitamins, nutrients, drugs, dyes, nucleic acid complexes, and imaging agents.
26. The method of claim 25 , wherein the substance is a drug.
27. A method of inducing binding affinity for a biological target in a polymer according to claim 4 , comprising the step of attaching a targeting moiety to one or more of the reactive functional groups X present on the polymer.
28. The method of claim 27 , wherein the biological target is the surface of a cell or virus.
29. The method of claim 28 , wherein the targeting moiety is selected from the group consisting of receptor-specific ligands, antibodies, antibody fragments, peptides comprising an RGD amino acid sequence, peptides comprising a YISRG motif, growth factors, as sialic acid derivatives, N-acetylneuraminic acid derivatives; folate, methotrexate, pteroic acid, estradiol, estratriol, testosternone, mannose-6-phosphate, sugars, vitamins, tryptophan, aminoalkyladamantanes, Fuzeon™, PRO-542, BMS-488043, sialic acid, 2-deoxy-2,3-didehydro-N-acetylneuraminic acid, 4-guanidino-Neu5Ac2en (zanamivir), oseltamivir, and RWJ-270201.
30. The method of claim 29 , wherein the targeting moiety is a monoclonal antibody or an antibody fragment.
31. The method of claim 24 , wherein the substance is selected from the group consisting of vitamins, nutrients, drugs, dyes, nucleic acid complexes, and imaging agents.
32. The method of claim 31 , wherein the substance is a drug.